Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Transarterial Chemoembolization in Patients With Elevated Bilirubin

NCT03259581 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT03259581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03259581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Transarterial Chemoembolization in Patients With Elevated Bilirubin
Lead sponsor
University of Minnesota
Phase
Phase 1
Overall status
Completed
Start date
January 2, 2018
Completion date
February 1, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bilirubinemia, hepatocellular carcinoma